Medical treatment in addition to a primary treatment to maximise effectiveness.
1Upstaging occurred in one case which may have ramifications for adjuvant therapy.
2Radiation therapy with weekly cisplatin administration was then given as adjuvant therapy.
3No significant association was detected in patients not treated with adjuvant therapy.
4The tumors were treated by surgical excision, with no adjuvant therapy given.
5Further improvement in long-term survival will depend on advances in adjuvant therapy.
6Inclusion of these patients into adjuvant therapy trials examining survival is inappropriate.
7PlGF could be a target of adjuvant therapy and deserves further investigations.
8Surgical resection is the mainstay of treatment because adjuvant therapy is unproven.
9If lymphadenectomy is not adequately performed, postoperative adjuvant therapy should be recommend.
10However, data regarding the role of adjuvant therapy in early LCNEC are limited.
11However, there was no significant difference in BCR-free survival regardless of adjuvant therapy.
12Currently no effective chemotherapy exists, and the value of adjuvant therapy remains unproved.
13No recurrence phenomenon has been observed after 12 months without any adjuvant therapy.
14Expanded use of adjuvant therapy for early-stage disease may also improve patient outcomes.
15Six patients were treated with curative intent, 5 received adjuvant therapy.
16This group should be followed closely for recurrence and considered for adjuvant therapy.
Translations for adjuvant therapy